Cost considerations in headache treatment part 2: Acute migraine treatment

Headache

Volumn 36, Issue 8, 1996, Pages 493-502

  Von Seggern, Randal L ^a   Adelman, James U ^a  

^a Adelman Headache Center   (United States)

Author keywords

cost effective; headache; medication costs; migraine; migraine abortive medication

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; CAFFEINE; CHLORPROMAZINE; DICLOFENAC; DIHYDROERGOTAMINE; ERGOTAMINE; ETODOLAC; FLURBIPROFEN; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; METOCLOPRAMIDE; NABUMETONE; NAPROXEN; NARCOTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; NOSE SPRAY; OXAPROZIN; PARACETAMOL; PETHIDINE; PIROXICAM; PROCHLORPERAZINE MALEATE; PROMETHAZINE; SUMATRIPTAN; THIETHYLPERAZINE MALEATE; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

ADJUVANT THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG TOLERANCE; EMERGENCY WARD; HEADACHE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MEDICAL DECISION MAKING; MIGRAINE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TABLET; TOPICAL DRUG ADMINISTRATION; VERTIGO; VOMITING;

ACUTE DISEASE; ADJUVANTS, PHARMACEUTIC; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIEMETICS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG THERAPY, COMBINATION; HUMANS; MIGRAINE DISORDERS; UNITED STATES;

EID: 0029816076     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3608493.x     Document Type: Review

References (31)

1. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the United States. PharmacoEconomics. 1992;2:67-76.
2. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33:29-35.
3. Adelman JU, Von Seggern R. Cost considerations in headache treatment. Part I: Prophylactic migraine treatment. Headache. 1995;35:479-487.
4. Mathew NT. The abortive treatment of migraine. In: Gallagher RM, ed. Drug Therapy for Headache. New York, NY: Marcel Dekker, Inc; 1991:95-113.
5. Davidoff RA. Treatment of the acute attack. In: Migraine: Manifestations, Pathogenesis, and Management. Philadelphia, Penn: F.A. Davis Co; 1995:194-220.
6. Kunkel RS. Medical management of acute migraine episode. In: Tollison CD, Kunkel RS, eds. Headache Diagnosis and Treatment. Baltimore, Md: Williams & Wilkins; 1993:85-88.
7. Volans GN. Migraine and drug absorption. Clin Pharmacokinet. 1978;3:313-318.
8. Hakkarainen H, Allonen H. Ergotamine vs. meto- clopramide vs. their combination in acute migraine attacks. Headache. 1982;22:10-12.
9. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol. 1965;2:57-63.
10. The Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992;32:177-184.
11. Tfelt-Hansen P, Scheldewaert R, Chaxot G. Treatment of migraine crisis by oral lysine acetylsalicylic acid + metoclopramide versus oral sumatriptan and placebo: socio-economic consequences. Presented at the meeting of the International Headache Congress, Toronto, Canada, 1995.
12. Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain. 1991;44:151-155.
13. Dalessio DJ. Caffeine as an analgesic adjuvant: review of the evidence. Headache. 1994;34(suppl 1):10-12.
14. Pradalier A, Clapin A, Dry J. Treatment review: non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks. Headache. 1988;28:550-557.
15. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs - differences and similarities. N Engl J Med. 1991;324:1716-1725.
16. Halpern LM. Analgesic pharmacology in management of headache pain. In: Tollison CD, Kunkel RS, eds. Headache Diagnosis and Treatment. Baltimore, Md: Williams & Wilkins; 1993:383-390.
17. Mathew NT. The abortive treatment of migraine. In: Gallagher RM, ed. Drug Therapy for Headache. New York, NY: Marcel Dekker, Inc; 1991:98.
18. Forbes JA, Beaver WT, Jones KF, et al. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin Pharmacol Ther. 1991;49:674-684.
19. Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache. 1976; 15:282-287.
20. Yuill GM, Swinburn WR, Liversedge LA. A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Br J Clin Pract. 1972;26:76-79.
21. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol. 1991;31:314-322.
22. Schmidt R, Fanchamps A. Effect of caffeine on intestinal absorption of ergotamine in man. Eur J Clin Pharmacol. 1974;7:213-216.
23. Adelman JU, Sharfman M, Johnson R, et al. Impact of oral sumatriptan on health-related quality of life and productivity in nursing personnel with migraine: an interim analysis. Presented at the meeting of the International Headache Congress, Toronto, Canada, 1995.
24. Cutler M, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology. 1995;45(suppl 7):S5-S9.
25. Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology. 1995;45(suppl 7):S10-S14.
26. Ensink F-BM. Subcutaneous sumatriptan in the acute treatment of migraine. J Neurol. 1991;238:S66-S69.
27. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171.
28. Schran HF, Tse FL. Pharmacokinetics of dihydroergotamine following subcutaneous administration in humans. Int J Clin Pharmacol Toxicol. 1985;23:1-4.
29. Salonen R, Ashford E, Dahlof C, et al. Intranasal sumatriptan for the acute treatment of migraine. J Neurol. 1994;241:463-469.
30. Kudrow L, Kudrow DB, Sandweiss JH. Rapid and sus- tained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache. 1995; 35:79-82.
31. Hakkarainen H, Gustafsson B, Stockman O. A comparative trial of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache. 1978;18:35-39.